Angel One - Share Market Trading and Stock Broking
Skip to main content

Live Myriad Genetics Inc Share Price Chart

O H L

Myriad Genetics Inc Performance Overview

Days Range
▼
$4.07Low
$4.28High

Markets Today

Previous Close$4.08
Open$4.08
Volume1,849,031
Day's Range$4.07 - $4.28
52W Range$2.74 - $8.59
Market Cap$401.73 M

Historical Performance

1M Returns+6.96
3M Returns-34.23
6M Returns-20.04
1Y Returns-48.77
5Y Returns-86.93
10Y Returns-78.51

Myriad Genetics Inc Fundamentals

Market Cap$401.73 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$824.50 M
ROE TTM-0.68
EPS TTM$-1.20
Quarterly Earnings Growth YOYN/A
PB Ratio1.32
EBITDA$-14.10 M
Profit Margin-44.38
Market Cap$401.73 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$824.50 M
ROE TTM-0.68
EPS TTM$-1.20
Quarterly Earnings Growth YOYN/A
PB Ratio1.32
EBITDA$-14.10 M
Profit Margin-44.38

Myriad Genetics Inc Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$195.90 M$213.10 M$205.70 M$209.80 M$200.40 M$190.70 M
Gross Profit +$134.20 M$151.80 M$143.80 M$146.80 M$137.60 M$127.00 M
Operating Income -$29.00 M-$329.20 M-$23.30 M-$5.70 M-$30.70 M-$38.90 M
EBITDA -$14.60 M$1.60 M-$10.70 M$9.60 M-$12.80 M-$26.40 M
Interest Expense -$800.00 K-$1.50 M-$3.80 M-$4.40 M-$4.10 M-$4.10 M
Depreciation $14.40 M$330.80 M$12.60 M$15.30 M$17.90 M$12.50 M
Income Before Tax -$29.40 M-$330.60 M-$26.20 M-$8.90 M-$34.10 M-$42.60 M
Income Tax Expense -$29.30 M-$100.00 K$1.20 M-$1.00 M$0$600.00 K
Net Income +-$100.00 K-$330.50 M-$27.40 M-$7.90 M-$34.10 M-$43.20 M
Net Profit Margin -0.05%-155.09%-13.32%-3.77%-17.02%-22.65%

Myriad Genetics Inc Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $900.00 K$900.00 K$900.00 K$900.00 K$900.00 K$1.00 M
Reserve & Surplus -$757.50 M-$1.09 B-$1.11 B-$1.12 B-$1.16 B-$1.20 B
Non-Current Liabilities $150.10 M$89.30 M$207.30 M$204.80 M$206.10 M$204.30 M
Current Liabilities $151.10 M$199.90 M$148.00 M$133.80 M$130.20 M$130.70 M
Total Liabilities $301.20 M$289.20 M$355.30 M$338.60 M$336.30 M$335.00 M
Fixed Assets $371.50 M$283.10 M$274.50 M$267.40 M$257.20 M$247.90 M
Current Assets $287.20 M$284.30 M$344.80 M$332.60 M$312.80 M$289.00 M
Total Assets $1.01 B$677.30 M$728.10 M$706.60 M$673.70 M$638.90 M

Myriad Genetics Inc Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$100.00 K-$330.50 M-$27.40 M-$7.90 M-$34.10 M-$43.20 M
Operating Cash Flow -$16.30 M-$13.60 M$21.10 M$10.60 M-$15.70 M-$8.30 M
Investing Cash Flow -$8.30 M-$6.90 M-$6.20 M-$6.00 M-$6.50 M-$3.20 M
Financing Cash Flow $13.60 M$2.60 M$56.20 M-$8.20 M-$3.00 M$2.20 M
Change in Cash -$10.90 M-$17.30 M$71.10 M-$3.50 M-$25.30 M-$9.20 M

Myriad Genetics Inc Return Calculator

The Myriad Genetics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,241
Invested Amount$10,000
Est. Returns$-8,759
Invest in USA Stock Today

About Myriad Genetics Inc

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

FAQs

Myriad Genetics Inc (MYGN) share price as of October 15, 2026 is $3.94. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Myriad Genetics Inc (MYGN) Share by opening an international trading account with Angel One.
Purchasing Myriad Genetics Inc (MYGN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Myriad Genetics Inc (MYGN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Myriad Genetics Inc (MYGN) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Myriad Genetics Inc on October 15, 2026, is $401.73 M.
Myriad Genetics Inc operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Myriad Genetics Inc (MYGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL